Explore KEYTRUDA® patient profiles
Explore efficacy and safety profile results for KEYTRUDA® advanced or metastatic esophageal carcinoma, in the first-line setting
Discover results from the KEYNOTE-590 trialExplore efficacy and safety profile results for KEYTRUDA® advanced or metastatic esophageal carcinoma, in the first-line setting
Discover results from the KEYNOTE-590 trialExplore efficacy and safety profile results for KEYTRUDA® advanced or metastatic esophageal carcinoma, in the first-line setting
Discover results from the KEYNOTE-590 trialExplore efficacy and safety profile results for KEYTRUDA® advanced or metastatic esophageal carcinoma, in the first-line setting
Discover results from the KEYNOTE-590 trialAE= adverse event; CPS=combined positive score; ECOG PS=Eastern Cooperative Oncology Group performance status; EGJ=esophagogastric junction; ESCC=esophageal squamous cell carcinoma; NCCN=National Comprehensive Cancer Network®; PD-L1=programmed death-ligand 1.
†Fictitious patient profile. May not be representative of all patients.
References:
- 1. KEYTRUDA® Product Monograph. Merck Canada Inc. April 19, 2023.
- 2. Health Canada Notice of Compliance Search. https://health-products.canada.ca/noc-ac/index-eng.jsp. Accessed September 27, 2022.
- 3. American Cancer Society. What is Esophageal Cancer? Accessed August 6, 2022. Available at:https://www.cancer.org/cancer/esophagus-cancer/about/what-is-cancer-of-the-esophagus.html.
- 4. Marieb EN. The Digestive System and Body Metabolism (Chapter 14). Essentials of Human Anatomy & Physiology, 7th Edition. Copyright © 2003 Pearson Education, Inc.
- 5. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Esophageal Cancer V.2.2022. © National Comprehensive Cancer Network, Inc. 2021. All rights reserved. Accessed February 18, 2022. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
CA-PDO-00148